Brokerages Set Pediatrix Medical Group, Inc. (NYSE:MD) Target Price at $22.50

Pediatrix Medical Group, Inc. (NYSE:MD) has earned a consensus recommendation of “Hold” from the six brokerages that are covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $22.50.

Several equities analysts recently issued reports on MD shares. Mizuho set a $24.00 target price on shares of Pediatrix Medical Group in a report on Friday, May 8th. Deutsche Bank Aktiengesellschaft set a $19.00 target price on Pediatrix Medical Group in a research note on Friday, February 20th. Jefferies Financial Group reaffirmed a “buy” rating and set a $27.00 target price on shares of Pediatrix Medical Group in a research note on Monday, April 20th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Friday, March 27th. Finally, Truist Financial boosted their target price on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a research report on Monday, April 13th.

Pediatrix Medical Group Stock Performance

NYSE:MD opened at $21.54 on Friday. The company has a market capitalization of $1.77 billion, a PE ratio of 10.46 and a beta of 0.70. The company has a 50 day simple moving average of $21.98 and a two-hundred day simple moving average of $21.73. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.33 and a current ratio of 1.33. Pediatrix Medical Group has a fifty-two week low of $11.84 and a fifty-two week high of $24.99.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The business had revenue of $476.20 million during the quarter, compared to the consensus estimate of $465.83 million. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.33 EPS. Research analysts anticipate that Pediatrix Medical Group will post 2.08 earnings per share for the current year.

Insider Activity

In related news, Director Shirley A. Weis sold 36,028 shares of the business’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total transaction of $855,665.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 1.80% of the stock is owned by insiders.

Institutional Trading of Pediatrix Medical Group

Several large investors have recently made changes to their positions in MD. Keybank National Association OH raised its stake in shares of Pediatrix Medical Group by 2.0% in the first quarter. Keybank National Association OH now owns 22,941 shares of the company’s stock worth $491,000 after purchasing an additional 458 shares during the last quarter. Smartleaf Asset Management LLC boosted its holdings in Pediatrix Medical Group by 10.6% during the 3rd quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company’s stock worth $101,000 after acquiring an additional 601 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in Pediatrix Medical Group by 4.5% during the 3rd quarter. PNC Financial Services Group Inc. now owns 14,525 shares of the company’s stock worth $243,000 after acquiring an additional 631 shares during the last quarter. Gotham Asset Management LLC boosted its holdings in Pediatrix Medical Group by 0.6% during the 3rd quarter. Gotham Asset Management LLC now owns 116,093 shares of the company’s stock worth $1,945,000 after acquiring an additional 724 shares during the last quarter. Finally, ProShare Advisors LLC boosted its holdings in Pediatrix Medical Group by 4.6% during the 4th quarter. ProShare Advisors LLC now owns 16,816 shares of the company’s stock worth $360,000 after acquiring an additional 734 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.